AB
WHWK

Amalgamated Bank’s Whitehawk Therapeutics WHWK Stock Holding History

Amalgamated Bank’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-502
Closed -$1K – 3129
2024
Q1 		$1K Sell
502
-868
-63% -$1.67K ﹤0.01% 2944
2023
Q4 		$3K Sell
1,370
-150
-10% -$629 ﹤0.01% 2971
2023
Q3 		$7K Hold
1,520
– – ﹤0.01% 2955
2023
Q2 		$10K Sell
1,520
-501
-25% -$3.9K ﹤0.01% 2964
2023
Q1 		$15K Sell
2,021
-303
-13% -$3.24K ﹤0.01% 2746
2022
Q4 		$30K Hold
2,324
– – ﹤0.01% 2626
2022
Q3 		$33K Buy
2,324
+35
+2% +$460 ﹤0.01% 2644
2022
Q2 		$28K Buy
+2,289
New +$34K ﹤0.01% 2755

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Amalgamated Bank's WHWK Position: Q2 2024 in Review

Amalgamated Bank sold out of Whitehawk Therapeutics (WHWK) in Q2 2024, closing a stake of 502 shares — an estimated $1K sold.

Amalgamated Bank first reported a position in WHWK in Q2 2022 and held it in 8 quarters. The position peaked at $33K in Q3 2022. 65 funds tracked by Wall St. Rank hold WHWK as of Q2 2024.

  • Amalgamated Bank reported no remaining Whitehawk Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Amalgamated Bank sold 502 Whitehawk Therapeutics shares in Q2 2024, an estimated $1K.
  • Amalgamated Bank first reported a position in Whitehawk Therapeutics in Q2 2022 and held it in 8 quarters.
  • Amalgamated Bank's Whitehawk Therapeutics position peaked at $33K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2024.

Based on Amalgamated Bank's 13F filing for Q2 2024, filed 12 Aug 2024.